MKI67 and myocardial infarction: Immunofluorescence analysis for Ki-67 showed an increased cell and fibroblast proliferation in non-infarcted myocardium in MI compared to sham group, which is almost completely abrogated by treatment with valsartan (MI vs. sham and MI vs. MI+Val p<0.001; Fig 5B).